Alzheimers Disease Completed Phase Trials for Liraglutide (DB06655)

IndicationStatusPhase
DBCOND0036596 (Alzheimers Disease)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01469351Identifying Potential Effects of Liraglutide on Degenerative ChangesTreatment